Showing results (11-20 of 127) with videos related to
Sort By:
Pageof 13
Drugs - Real World Outcomes|October 18, 2016
Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment ImplicationsJohn D Hainsworth, F Anthony GrecoClinical Lung Cancer|November 12, 2003
Emerging role of topotecan in first-line therapy of small-cell lung cancerF Anthony Greco, John D HainsworthClinical Lung Cancer|January 15, 2004
The role of weekly docetaxel in the treatment of advanced non-small-cell lung cancerJohn D Hainsworth, F Anthony GrecoClinical Genitourinary Cancer|April 4, 2018
Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient SubsetF Anthony Greco, John D HainsworthClinical Advances in Hematology & Oncology : H&O|November 1, 2005
Evolving role of irinotecan in small-cell lung cancerDavid R Spigel, F Anthony GrecoVirchows Archiv : an International Journal of Pathology|February 4, 2014
Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of careJohn D Hainsworth, F Anthony GrecoClinical Lung Cancer|May 8, 2009
What is the role of novel taxanes in non-small-cell lung cancer?David R Spigel, F Anthony GrecoCancer Investigation|November 27, 2002
Paclitaxel and mitoxantrone in the treatment of metastatic breast cancer: a phase II trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, Sharon Calvert, F Anthony GrecoSeminars in Oncology|January 31, 2009
Neuroendocrine carcinoma of unknown primary siteDavid R Spigel, John D Hainsworth, F Anthony GrecoJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network StudyJohn D Hainsworth, David R Spigel, Sharlene Litchy, et al.Pageof 13